Skip to main content

Advertisement

SpringerLink
Log in

The relationship between cytokines and pain/depression: A review and current status

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Cytokines are small protein molecules secreted in response to immune stimuli. Recent research has outlined important roles for proinflammatory cytokines in the cascade of normal physiologic responses to environmental stresses, encompassing so-called sickness behavior that is thought to be an adaptive response to infection and other illnesses. Cytokines are involved in signaling that activates central nervous system glial cells. This activation is part of a poorly understood interaction between immune challenge or injury and host that can lead to the development or facilitation of persistent mood symptoms or pathologic pain. This article reviews evidence that may enhance our understanding of how pathologic symptoms, such as mood disorders and neuropathic pain, may emerge from proinflammatory cytokine activation. Possible conceptualizations of these illnesses and potential treatment implications are explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Horst Ibelgauft’s COPE with Cytokines. Available at http://www.copewithcytokines.de. Accessed October 10, 2006.

  2. Ransohoff RM, Benveniste EN: Cytokines and the CNS. New York: Taylor & Francis; 2006.

    Google Scholar 

  3. Smith DD: Optimization of cellular ELISA for assay of surface antigens on human synoviocytes. Biotechniques 1997, 22:952–957.

    PubMed  CAS  Google Scholar 

  4. Dinarello CA. Proinflammatory cytokines. Chest 2000, 118:503–508.

    Article  PubMed  CAS  Google Scholar 

  5. Hart BL: Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988, 12:123–137.

    Article  PubMed  CAS  Google Scholar 

  6. Maier SF, Watkins LR: Cytokine for psychologists: implications for bi-directional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Rev 1998, 105:83–107.

    Article  CAS  Google Scholar 

  7. Kent S, Bluthe RM, Kelley KW, Dantzer R: Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992, 13:24–28.

    Article  PubMed  CAS  Google Scholar 

  8. Parnet P, Kelley KW, Bluthe RM: Expression and regulation of IL-1 receptors in the brain. Role in cytokine-induced sickness behavior. J Neuroimmunol 2002, 125:5–14.

    Article  PubMed  CAS  Google Scholar 

  9. Gutierrez EG, Banks WA, Kastin AJ: Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993, 47:169–176.

    Article  PubMed  CAS  Google Scholar 

  10. Gutierrez EG, Banks WA, Kastin AJ: Blood-borne interleukin-1 receptor antagonist crosses the blood brain barrier. J Neuroimmunol 1994, 55:153–160.

    Article  PubMed  CAS  Google Scholar 

  11. Illman J, Corringham R, Robinson D, et al.: Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 2005, 3:37–50.

    PubMed  CAS  Google Scholar 

  12. Leonard BE: The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:767–780.

    Article  PubMed  CAS  Google Scholar 

  13. Ramamoorthy S, Ramamorthy JD, Pradad P, et al.: Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun 1995, 216:560–567.

    Article  PubMed  CAS  Google Scholar 

  14. Wilson CR, Finch CE, Cohen HJ: Cytokines and cognition—the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002, 50:2041–2056.

    Article  PubMed  Google Scholar 

  15. Penninx BW, Kritchevsky SB, Yaffe K, et al.: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003, 54:566–572.

    Article  PubMed  CAS  Google Scholar 

  16. Capuron L, Ravaud A, Neveu PJ, et al.: Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 2002, 7:468–473.

    Article  PubMed  CAS  Google Scholar 

  17. Delgado PL, Price LH, Miller HL, et al.: Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Genet Psychol 2004, 51:865–874.

    Google Scholar 

  18. Musselman DL, Lawson DH, Gumnick JF et al.: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961–966.

    Article  PubMed  CAS  Google Scholar 

  19. Capuron L, Ravaud A, Gualde N, et al.: Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2 based therapy. Psychoneuroendocrinology 2001, 26:797–808.

    Article  PubMed  CAS  Google Scholar 

  20. Capuron L, Ravaud A, Neveu PJ, et al.: Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 2002, 7:468–473.

    Article  PubMed  CAS  Google Scholar 

  21. Demetrashvilli M, Raison CL, Miller AH: Depression in at-risk populations. Cent Nerv Syst News 2002, 4:9–12.

    Google Scholar 

  22. Cleeland CS, Bennett GJ, Dantzer R, et al.: Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003, 97:2919–2925.

    Article  PubMed  Google Scholar 

  23. Trikha M, Corringham R, Klein B, et al.: Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 2003, 9:4653–4665.

    PubMed  CAS  Google Scholar 

  24. Musselman DL, Miller AH, Porter MR, et al.: Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychol 2001, 158:1252–1257.

    Article  CAS  Google Scholar 

  25. Pace TWW, Miletzko TC, Alagbe O, et al.: Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychol 2006, 163:1630–1633.

    Article  Google Scholar 

  26. Castanon N, Leonard BE, Neveu PJ, Yirmiya R: Effects of antidepressants on cytokine production and actions. Brain Behav Immun 2002, 16:569–574.

    Article  PubMed  CAS  Google Scholar 

  27. Pollak Y, Yirmiya R: Cytokine-induced changes in mood and behavior: implications for “depression due to a general medical condition,” immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 2002, 5:389–399.

    Article  PubMed  CAS  Google Scholar 

  28. Leonard BE: The immune system, depression, and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:767–780.

    Article  PubMed  CAS  Google Scholar 

  29. Wieseler-Frank J, Maier SF, Watkins L: Central proinflammatory cytokines and pain enhancement. Neurosignals 2005, 14:166–174.

    Article  PubMed  CAS  Google Scholar 

  30. Watkins LR, Maier SF: Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005, 257:139–155.

    Article  PubMed  CAS  Google Scholar 

  31. Myers RR, Wagner R, Sorkin LS: Hyperalgesic actions of cytokines on peripheral nerves. In Cytokines and Pain. Edited by Watkins LR, Maier SF. Basel, Switzerland: Birkhause; 1999:133–158.

    Google Scholar 

  32. Twining CM, Sloane EM, Milligan ED, et al.: Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats. Pain 2004, 110:299–309.

    Article  PubMed  CAS  Google Scholar 

  33. Lindenlaub T, Sommer C: Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 2003, 105:593–602.

    PubMed  CAS  Google Scholar 

  34. Kagan BL, Baldwin RL, Munoz D, et al.: Formation of ionpermeable channels by tumor necrosis factor-alpha. Science 1992, 255:1427–1430.

    Article  PubMed  CAS  Google Scholar 

  35. Qiu Z, Sweeney DD, Netzeband JF, et al.: Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 1998, 18:10445–10456.

    PubMed  CAS  Google Scholar 

  36. Sweitzer SM, Colburn RW, Rutkowski M, et al.: Acute peripheral inflammation induces moderate glial activation and spinal IL-1 beta expression that correlates with pain behavior in the rat. Brain Res 1999, 829:209–221.

    Article  PubMed  CAS  Google Scholar 

  37. Sweitzer SM, Martin D, DeLeo JA: Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001, 103:529–539.

    Article  PubMed  CAS  Google Scholar 

  38. Raison CL, Nemeroff CB: Cancer and depression: prevalence, diagnosis, and treatment. Home Health Consult 2000, 7:34–41.

    Google Scholar 

  39. Baldessarini RJ, Tondo L, Davis P, et al.: Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006, 8:625–639.

    Article  PubMed  CAS  Google Scholar 

  40. Frank E, Thase M: Natural history and preventative treatment of recurrent mood disorders. Annu Rev Med 1999, 50:453–468.

    Article  PubMed  CAS  Google Scholar 

  41. Xie W, Strong J, Meij J: Neuropathic pain: early spontaneous afferent activity is the trigger. Pain 2005, 116:243–256.

    Article  PubMed  Google Scholar 

  42. Foley KM: Opioids and chronic neuropathic pain. N Engl J Med 2003, 348:1279–1281.

    Article  PubMed  Google Scholar 

  43. Lloyd AJ, Ferrier IN, Barber R, et al.: Hippocampal volume change in depression: late-and early-onset illness compared. Br J Psychol 2004, 184:488–495.

    Article  Google Scholar 

  44. Apkarian AV, Sosa Y, Sonty S, et al.: Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. Neuroscience 2004, 24:10410–10415.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCLA Department of Psychiatry and Biobehavioral Sciences, Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, UCLA and Cedars-Sinai Medical Centers, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA

    Thomas B. Strouse MD

Authors
  1. Thomas B. Strouse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas B. Strouse MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strouse, T.B. The relationship between cytokines and pain/depression: A review and current status. Curr Pain Headache Rep 11, 98–103 (2007). https://doi.org/10.1007/s11916-007-0005-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-007-0005-y

Keywords

Search

Navigation